Previous close | 158.45 |
Open | N/A |
Bid | 183.00 |
Ask | 193.00 |
Strike | 280.00 |
Expiry date | 2026-01-16 |
Day's range | 158.45 - 158.45 |
Contract range | N/A |
Volume | |
Open interest | 1 |
On May 2, 2024, Director Sangeeta Bhatia sold 467 shares of Vertex Pharmaceuticals Inc (NASDAQ:VRTX) as reported in a recent SEC Filing.
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $400.16, representing a -0.49% change from its previous close.
Arcus Biosciences (RCUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.